论文部分内容阅读
目的:分析小细胞肺癌(SmallCellLungCancer,SCLC)胰腺转移的临床特点,探索提高预后生存质量的治疗方式。方法:回顾性分析14例小细胞肺癌胰腺转移的临床资料。结果:14例患者发生胰腺转移时的中位年龄为45.0岁,胰腺转移发生率为同期小细胞肺癌患者的0.63%,12例已死亡病例中发生胰腺转移后生存期为1.5～44个月,中位生存时间为11个月。结论:小细胞肺癌发生胰腺转移临床上少见,但应争取早期明确诊断和积极治疗。
OBJECTIVE: To analyze the clinical features of pancreatic metastasis in small cell lung cancer (SCLC) and explore ways to improve the quality of life of patients with prognosis. Methods: The clinical data of 14 cases of small cell lung cancer with pancreatic metastasis were analyzed retrospectively. Results: The median age of 14 patients with pancreas metastasis was 45.0 years. The incidence of pancreas metastasis was 0.63% in patients with small cell lung cancer in the same period. The survival rate of pancreatic metastasis was 1.5 to 44 months in 12 patients who had died. The median survival time was 11 months. Conclusion: Pancreatic metastasis of small cell lung cancer is rare in clinical practice. However, early diagnosis and active treatment should be sought.